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Abstract
Background: The number of colorectal cancer patients increases with age. The decision to go through major
surgery can be challenging for the aged patient and the surgeon because of the heterogeneity within the older
population. Differences in preoperative physical and cognitive status can affect postoperative outcomes and
functional recovery, and impact on patients’ quality of life.
Methods / design: A prospective, observational, multicentre study including nine hospitals to analyse the impact
of colon cancer surgery on functional ability, short-term outcomes (complications and mortality), and their
predictors in patients aged ≥80 years. The catchment area of the study hospitals is 3.88 million people, representing
70% of the population of Finland. The data will be gathered from patient baseline characteristics, surgical
interventional data, and pre- and postoperative patient-questionnaires, to an electronic database (REDCap)
especially dedicated to the study.
Discussion: This multicentre study provides information about colon cancer surgery’s operative and functional
outcomes on older patients. A further aim is to find prognostic factors which could help to predict adverse
outcomes of surgery.
Trial registration: ClinicalTrials.gov (NCT03904121). Registered on 1 April 2019.
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The proportion of older people is increasing rapidly in
western countries. In Finland, the estimated portion of
the population aged over 70 will increase from the
current 15.8 to 20% in 2030 and 25% in 2070 [1]. As the
incidence of colon cancer increases with age [1, 2], the
number of colon cancer patients can also be expected to
increase, although the incidence has not dramatically
changed over the decades [2].
The primary recommended treatment for colon cancer
is surgery [3], but the decision to go through a major op-
eration can be challenging for both the aged patient and
the surgeon. Therefore, age-related concerns may lead
to undertreatment of older patients, who compose a het-
erogeneous group with vastly different physiological and
cognitive performance status [4]. Many older patients
may have significant comorbidities, poor nutritional, and
functional status [5, 6], which have been associated with
severe postoperative complications associated with
reduced 30-day and 1-year survival after colon cancer
surgery [7]. Careful assessment is therefore required to
make individual treatment decisions [8].
Modern medical and operative developments, includ-
ing perioperative anaesthesia care, surgical performance
(laparoscopy, technical standardisation), enhanced recov-
ery program (ERAS) and oncological treatments, have
improved outcomes for aged colorectal cancer patients
[9, 10]. The difference in short-term postoperative mor-
tality between older and younger colorectal patients has
reduced during the last decade [11]. Conversely, frailty, a
state of diminished physiological reserve capacity [12],
has been identified as a significant predictor of postoper-
ative complications leading to a prolonged hospital stay,
discharge to nursing homes or long-term care facilities,
and higher mortality rates than for fit patients [13, 14].
Preoperative screening tests for evaluating malnutrition,
functional performance status, anaesthesiologist risks,
and the cumulative burden of comorbidities can help
identify factors that increase the risks of postoperative
adverse events. However, comprehensive geriatric evalu-
ations are often time-consuming and demand resources,
highlighting the need for easily implemented screening
tools, which produce crucial and objective results [15].
Older patients commonly prioritise functional out-
comes before survival after cancer surgery [16]. Recent
studies from the Netherlands and Norway reported
positive impacts on quality of life after surgery for aged
patients with colorectal cancer [17, 18]. There is growing
evidence that physical and mental prehabilitation
strategies, together with innovative surgical and postoper-
ative treatments, can enhance long-term outcomes, func-
tional recovery, and quality of life after surgery [19, 20]. A
recently published international multicentre prospective
study, Geriatric Oncology Surgical Assessment and Func-
tional rEcovery after Surgery (GOSAFE), showed that
68.4% of patients over 70 years experiencing cancer sur-
gery are frail. Thus, frailty evaluation has an essential role
in predicting postoperative morbidity and mortality cor-
relating with quality of life and physical and cognitive
functional recovery [21].
There is little prospectively collected published data
about the influence of colorectal surgery on postopera-
tive outcomes and functional recovery for very old
patients. The consensus recommendations and studies
are mainly made for patients over 70 years [4, 8, 21]. Pa-
tients over 80 years are seldom included in prospective
clinical trials, so the optimal treatment of these patients
remains unclear [22]. In Finland, the incidence of colon
cancer patients over 80 years has increased from 183 to
216 per 100,000 in the past 20 years, and 28% of patients
were aged 80 years or more in 2018 [23]. Thus, it is sig-
nificant to have adequate and trustworthy information
about colon cancer surgery and its effect on postopera-
tive morbidity, functional recovery, and survival. Recog-
nition of frailty is essential to reduce adverse outcomes.
Preoperative real-life clinical data can provide objective
and helpful measures to the surgeons planning interven-
tions for aged patients [24]. These instruments should
accurately predict surgery’s adverse outcomes and be
easy to implement, and thus able to guide comprehen-
sive decision-making [25].
Objectives
This multicentre study aims to analyse the impact of
colon cancer surgery on patients over 80 years, their
functional ability, the occurrence of complications, and
mortality during the first postoperative year and high-
light predictors of these adverse outcomes. We also aim
to investigate non-operatively treated patients’ progress
and subsequent functional ability and survival [26].
Methods
Study design and setting
The study is an observational, prospective, cohort, multi-
centre study of patients aged 80 years or older diagnosed
with stage I-III colon cancer. The patients are treated
either non-operatively or with curative resection or a
palliative procedure. The participating hospitals are
Helsinki University Hospital, Tampere University Hos-
pital, Turku University Hospital, Central Finland Central
Hospital, North Karelia Central Hospital, Päijät-Häme
Central Hospital, Satakunta Central Hospital, South
Ostrobothnia Central Hospital and Vaasa Central Hospital.
The catchment area of the study hospitals is 3.88 million
people (of whom 219,900 are aged 80 years or over), repre-
senting 70.4% of Finland’s population [1].
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The public health care system almost exclusively per-
forms the treatment of malignant diseases in Finland.
All citizens have equal access to health care independent
of social or insurance status. These study hospitals
represent majority of Finnish hospitals operating colon
cancer patients. Hence, the study provides a nationwide
spectrum of operative management of colon cancer on
the aged population. The study is independent of any in-
dustrial sponsorships.
Participants
Patients aged 80 years or over with recently diagnosed
stage I-III colon cancer will be assessed for suitability for
inclusion. General practitioners or endoscopic units
make most consultations of colon cancer patients, so the
data includes only the patients referred to surgical units
for operative treatment.
Eligibility criteria (Fig. 1)
Inclusion criteria
– Stage I-III colon cancer
– Age 80 years or older at the time of recruitment
– The study’s information is approved and signed
by the patient, or a legally authorised
representative or family member if the patient’s
cognitive status has declined.
Exclusion criteria
– Metastatic cancer of any type at the time of
diagnosis with no possibility of curative surgery
– Patient undergoing emergency operation for colon
cancer
– The patient has an expected life expectancy of less
than 6 months due to colon cancer or other reasons.
Primary intervention
All the patients have a preoperative colonoscopy, computed
tomography, and presentation at a multidisciplinary team
(MDT) meeting. They will undergo either radical surgery
or a palliative procedure for the primary tumour, or nonop-
erative treatment according to hospital-standardised proto-
cols for treatment and follow-up based on national EBM
guidelines [27, 28]. The decision for definitive treatment
choice is made collectively with the patient or, when
needed, with a family member or legally authorised
representative.
Outcomes
The study’s primary outcomes are morbidity (surgical
and non-surgical complications) and mortality, and their
effect on functional recovery within 1 year after the pri-
mary surgical procedure, or after the date the decision
for non-operative treatment is made. Postoperative
Fig. 1 Eligibility criteria
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morbidity will be recorded during the hospital stay, and
at 30 days and 90 days after surgery, recorded at the out-
patient clinic. Postoperative morbidity (surgical and
non-surgical) will be assessed according to the Clavien-
Dindo (CD) classification [29]. Mild complications are
graded as CD I-II and severe complications as CD III-V.
It will be recorded if patients with non-operative treat-
ment require readmission to the study hospital. Mortal-
ity will be recorded at 30 days, 90 days and 1 year after
surgery, or after the date that the decision for non-
operative treatment is made.
Secondary outcomes are reoperations, length of hos-
pital stay, discharge destination, readmission rate, and
recruited patient (nursing home admission, mobility, and
self-related health status [30]).
Long-term outcomes concerning functional recovery
and mortality will be collected analogously 3 and 5 years
after the cancer treatment decision.
Tools for preoperative risk assessment
G-8: Onco-geriatric screening tool includes eight items
modified from MNA-SF, age, number of medications
and self-rated health status [31]. The G-8 score ranges
from 0 to 17. Geriatric evaluation is recommended for
patients whose score is ≤14 [32].
MNA-SF: Mini Nutritional Assessment-Short Form
describes nutritional status as the normal, risk of malnu-
trition or malnourished. The score ranges from 0 to 14
and with cancer patients from 0 to 12. The risk of mal-
nutrition is scored between 8 and 11 and malnourished
patients between 0 and 7 [33].
CFS: Canadian Study on Health and Aging Clinical
Frailty Scale, as assessed by the surgeon. The scale
ranges from 1 to 9. Patients are described as frail with
score ≥ 4 [34].
ASA: American Society of Anaesthesiologists physical
status classification, which evaluates preoperative anaes-
thesiologist risk. The score ranges from 1 to 5. Categor-
ies are divided as 1 (a normal healthy patient), 2 (a
patient with mild systemic disease, age > 65 years), 3 (a
patient with severe systemic disease that is not incapaci-
tating), 4 (a patient with an incapacitating systemic dis-
ease that is a constant threat to life), 5 (a dying patient
who is not expected to survive for 24 h with or without
operation) [35].
AA-CCI: Age-adjusted Charlson comorbidity index,
which identifies cancer patients with increased risk of
perioperative mortality. The scale ranges from 4 to 15;
solid tumour excluded with two points, all patients 80
years or older contribute four points [36].
Other information
Table 1 shows the information that is collected in
addition to the risk assessment tools. The study surgeons
record each patient’s baseline and data related to the
surgery, perioperative hospitalisation, postoperative
complications, and mortality. Patient-related question-
naires (Additional file 1) are collected before surgery,
one, three, six and twelve months after surgery or the
date non-operative treatment decision was made. The
questionnaires will be collected either during the out-
patient clinic visit, by telephone interview or by mail. All
the information from the data mentioned above is re-
corded to the electronic database (REDCap) by the study
surgeons. The dates and causes of death are obtained
from the Death Certificate Register of Statistics Finland,
which registers all deaths in Finland [37].
Recruitment
All patients aged 80 years or older who have been diag-
nosed with stage I-III colon carcinoma and are referred
to participating hospitals to consider surgery are eligible
for the study. Surgeons responsible for the treatment will
inform the patients about the possible advantages and
disadvantages of the intervention and the study protocol
of patient-questionnaires during their visit to the out-
patient clinic before the definitive treatment. The infor-
mation and consent forms are specially designed for the
study and include the surgeons responsible for recruit-
ment at each study site. After properly informed consent
is obtained, the patient is recruited to the study.
Non-operative treatment is chosen if the patient is
deemed unfit to survive the operation due to anaesthe-
siologic, physiological or cognitive status. If necessary,
an anaesthesiologist, cardiologist, the pulmonary or geri-
atric specialist is consulted in decision-making. Patients
may also refuse surgery after receiving information about
possible advantages and disadvantages of the procedure.
The ultimate decision will be made collectively with the
patient and, if possible, with relations.
Both non-operatively and operatively treated patients
are included, and they are not randomised in any way.
Allocation
The study is an observational, prospective study without
randomisation. All patients who voluntarily sign the
consent form are included in the study. According to
standardised protocols for treatment and follow-up, they
will be treated at the study hospitals based on national
EBM guidelines [27, 28]. The excluded patients are not
followed up.
Questionnaires used in the study
The pre-and postoperative questionnaires are specially
designed for the study and are all convergent. The ques-
tions survey living status, use of implements, outside
personal aid, functional and cognitive ability, and nutri-
tion utilising G-8, MNA-SF and CFS [31, 33, 34]. They
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are collected before surgery and one, three, six and
twelve months after surgery. The use of large font
size (Calibri 16) aims to help these older people to
answer the questions. The questionnaires are writing
in Finnish or Swedish thus patients can use their
native language.
Table 1 Collected information




Height and weight, BMI x
Medication x x x x x
ASA classification x
Clinical Frailty Scale-index (CFS) x
Comorbidities (include diseases subsumed in modifield
Charlson Comorbidity Index)
x
Haemoglobin, creatine, estimated GFR, albumin x
History of smoking and alcohol-consumption x x x x x
Other reported cancers excluding colon cancer x
Diagnostic procedures (colonoscopy, CT scan) x
Onco-geriatric screening tool (G-8) x x x x x
Mini Nutritional Assessment- Short Form (MNA-SF) x x x x x
Status of living x x x x x
Mobility x x x x x
Neuropsychological status x x x x x
Weight loss and food intake x x x x x
Self-related health status x x x x x
Patient information and approval x
INTERVENTION DATA
Date of operation x
Used surgical technique (laparoscopy, open, conversion) x
Curative or palliative operation x
Demand for stoma x
Operative time and blood lose x
POSTOPERATIVE DATA
Surgical complications (anastomotic leakage, bleeding,
ileus, wound dehiscence or infection, other)
Clavien-Dindo classification
x x x x
Non-surgical complications (cardiovascular, pulmonary,
urinary, delirium, other) Clavien-Dindo classification
x x x x
Reoperations x x x
Length of stay x x
Place of discharge x x
Readmissions x x x
Pathological report (TNM-status) x
Postoperative adjuvant treatment x x x
Recurrences (local and distant) x x x x
Date of death
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The questionnaires (Additional file 1) are composed of
following questions:
– status of living (home, nursing home, health centre
wards)
– mobility (with or without implements, outside help)
– neuropsychological problems
– nutrition (food intake, weight-loss)
– self-rated health status in comparison with other
people of the same age
– number of medications
– number of hospital admissions 6 months before the
index surgery
– smoking habits and alcohol consumption
– living will (yes or no)
Participant timeline
Recruitment started in April 2019 at Tampere University
Hospital. The data collected from the participants and
follow-up timeline is presented in Table 1. Short-term
outcomes, including discharge history and complica-
tions, will be monitored at discharge, 1 and 3 months
after primary operation by the surgeon responsible for
recruitment.
Sample size
The primary endpoints are the surgical and non-surgical
postoperative complications and mortality. Previously
published Finnish registry-based cohort studies on
patients over 80 years with colorectal cancer reported
complications rates 30–40% and severe complications
18–21%, respectively [7, 38]. In a large population-based
cohort study with very old colorectal cancer patients,
one-year mortality rates after surgery were 15–24% [39].
Frail patients had 2–3 times higher risk than non-frail
patients of developing moderate to severe complications
[14], leading to a disproportionately high risk of short-
term mortality. A recently published study showed five
times higher one-year mortality rate for patients with se-
vere complications (8.6 vs 45%) [7].
Based on expected incidences of complications of 30%
(fit patients) and 55% (frail patients), a sample size of
140 is needed to give 80% power to detect a significant
difference between CFS 1–3 vs ≥ 4 groups, with two-
sided type 1 error of 5%. Each group would comprise 70
patients. Additionally, with an estimated rate of one-year
mortality of 10% (fit patients) and 25% (frail patients),
we will need to study 113 frail subjects and 113 fit con-
trol subjects to be able to reject the null hypothesis that
the failure rates for frail and fit subjects are equal with
probability (power) 0.8. The type I error probability as-
sociated with this test of this null hypothesis is 0.05. We
will use a continuity-corrected chi-squared statistic or
Fisher’s exact test to evaluate this null hypothesis.
The first patient was included in the study 17th of
April 2019 and operated on 29th April 2019. The pre-
liminary estimate is that the final data will be collected
by the end of April 2021.
Data collection methods
Data management
An electronic database REDCap (https://www.project-
redcap.org/) is used to gather the study data. REDCap is
a secure web platform for building and managing online
databases and surveys with online and offline data sup-
port. The main investigators have designed a dedicated
version for this prospectively collected study data. All
the surgeons responsible for the study at their hospital
site receive a personal username and password for the
electronic database to handle the data with confidential-
ity. Access to the whole database is limited to the main
investigators in Tampere University Hospital and
Tampere University.
All patients receive a study number, and the identi-
fication key is kept separately from the database on a
username and password secured server at each study
site. Data will be entered manually from paper case
report forms (CRFs) into an electronic database
(REDCap) protected by an automatic backup of server
data and firewalls against external violation. All elec-
tronic case report forms (eCRFs) are handled with a
particular study ID.
The occurrence of relevant protocol deviations such as
metastatic disease, report of benign pathological tissue,
or refusal to continue in the study will be determined
and documented. Data verification and validation will be
performed, and the results are analysed with code num-
bers not to identify the patient. When patient data and
questionnaires have been coded, validated, and locked, a
clean file will be declared.
Data collection
The principal investigator at each study site is re-
sponsible for the data collection and is reviewed by
the main investigator. Each patient is asked to fill out
patient-questionnaires at the time of inclusion, and at
one, three, six and twelve months after surgery. If the
patient cannot complete the questionnaire, a family
member, legally authorised representative, or nurse in
charge of the patient will complete the form. The
principal investigators or research nurses of each
study site are charged with ensuring that the patient
questionnaires are completed.
Patients can resign from the study at any time during
the study period, in this event data collected before res-
ignation can be used in the analyses, following the last
observation carried forward to practice.
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Data monitoring
Instructions for data collection and storage have been
provided to the surgeons responsible for recruitment at
the study sites. The main investigator in Tampere
University Hospital, who has full access to the full study
register, will continuously monitor data. The other sur-
geons only have access to the patient register at their
study site hospital. Technical and statistical monitoring,
and advanced conduct with full access to the register, is
given to the statistics expert from Tampere University.
Statistical methods
Percentages will be used to describe demographic data
and the proportion of observed complications. The
mean and standard deviation will be reported for age
and the median and range for preoperative laboratory
values and body mass index (BMI). Associations between
the categorical variables are tested with the Chi-Square-
test or the Fisher exact test, when appropriate. A uni-
and multivariable analysis of the factors influencing
morbidity and mortality will be carried out using binary
logistic regression. All variables that were statistically
significant in the univariate model are included in the
multivariable model. Statistical analyses are performed
using SPSS version 27.
Ethics and dissemination
Research ethic approval
The study adheres to the Declaration of Helsinki on
medical research protocols and ethics. Each participating
hospital applies for study permission from the institu-
tional review boards at their unit. The Regional Ethics
Committee has approved the study protocol of the
Expert Responsibility area of Tampere University Hospital
(reference approval number R19028).
Protocol amendments
Significant protocol modifications are communicated
with the Regional Ethics Committee of the Expert
Responsibility area of Tampere University Hospital by
amendments. All changes are also registered at Clinical-
Trials.gov (NCT03904121).
Confidentiality
Patient confidentiality will be strictly maintained.
Patients will be assigned a study ID, and all data will be
handled without a name or personal social security
number. Access to patient records is limited to the study
group and the investigator-delegated study coordinator.
Dissemination policy
According to an agreement with the internationally ac-
cepted guidelines for authorship (International Committee
of Medical Journal Editors), the study group members
who are actively planning, recruiting, analysing, or writing
will be part of the writing committee. Results will be pub-
lished in peer-reviewed scientific journals. Results will also
be communicated through professional meetings and the
media.
Discussion
With the increased life expectancy with the world popu-
lation, the risk of developing colon cancer grows [2].
The decision to progress with invasive treatment can be
challenging, as it should consider differences in pre-
operative physical and cognitive status that affect post-
operative outcomes and functional recovery among the
older population [19, 40]. Because of these differences,
decision-making should not be based only on age.
Instead, surgeons should evaluate the severity of comor-
bidities, functional and cognitive performance status to
optimise a patient’s preoperative condition. Pre-
operative risk assessments of postoperative outcomes,
recognition of frailty, and identification of patients at
greater risk of unfavourable treatment consequences,
should be easy to implement.
This prospective, multicentre study will analyse colon
cancer surgery’s impact on patients over 80 years, a pa-
tient group that will increase markedly in the coming
years [1, 23]. The main objectives are short-term out-
comes during the first postoperative year and their influ-
ences on functional ability and survival. These short-
term outcomes are relevant as older colon cancer pa-
tients’ prognosis seems to be quite good (60% surviving
at 5 years) if they avoid postoperative complications and
survive the first postoperative year [41, 42].
Recent data from the GOSAFE study showed that
68.4% of patients were considered frail according to the
G-8 score (≤14), and 36% had a cumulative burden of
comorbidities (AA-CCI ≥7). In that study, 36.8% of pa-
tients were aged ≥80 years [21]. The present study will
focus only on patients 80 years or older with potentially
curable colon cancer. The very old express significant
heterogeneity in physical and cognitive status, so we can
expect frail patients with functional and cognitive im-
pairment. In Finland, the life expectancy of an 80-year-
old person is 8.3 years (male) and 10.2 years (female) [1],
so it is essential to identify and evaluate prognostic fac-
tors, both favourable and adverse, which may predict
how these patients recover from radical operative treat-
ment. The collected data include readily available
patient-related information about preoperative func-
tional performance, preoperative examinations, the sur-
gery, and the early postoperative course. Thereby, it
allows analysis of patient- and surgery-related factors as
predictors of early postoperative complications. Another
advantage is that, unlike most previous studies, the study
will also include non-operatively treated patients from
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the same hospitals, allowing evaluation of patient-
selection and possible side-effects of non-operative
treatment.
Although an observational study cannot answer
whether the surgery is beneficial or not, performing a
randomised trial in this patient group is not realistic.
Instead, it is clinically more relevant to study outcomes
in an observational setting with less selection bias and
more relevance to real-life. This study’s strengths in-
clude examining a representative cohort, independent of
social or insurance status, treated at several secondary
and tertiary care hospitals instead of single-centre ana-
lysis. The multicentre nature of this study also allows for
the timely collection of the data. It is acknowledged that
the tests used (e.g. G-8, Clinical Frailty Scale, MNA-SF,
CCI) represent screening tests, and more thorough geri-
atric evaluation would be needed for precise diagnoses.
However, geriatric services are not widely available in
surgical units at present. Evaluation of comprehensive
geriatric assessment and preoperative optimisation pro-
tocols [43] in older colon cancer patients remains a
question for later studies. The present results could,
however, provide the basis for patient-selection in such
later intervention studies.
This is the first prospective, observational, multicentre
study of aged Finnish patients with non-metastatic colon
cancer focusing on their treatment and its effects on
postoperative outcomes and functional recovery. Finland
follows uniform and standardised protocols for colon
cancer treatment so that this study will provide realistic
and novel information on aged patients postoperative
functional recovery.
Trial status
The trial recruitment started on 17 April 2019, and it is
estimated to be complete by the end April 2021.
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